CRUK/98/001 - SECRAB - A Phase III Study of Sequential v. Synchronous Chemotherapy and Radiotherapy in the Adjuvant Treatment of Early Breast Cancer

Fernando, Indy (Principal Investigator)

Cancer and Genomic Sciences

Short title	CRUK/98/001 - SECRAB - A Phase III Study of Sequential v. Synchronous Chemotherapy and Radiotherapy in the Adjuvant Treatment of Early Breast Cancer
Status	Finished
Effective start/end date	1/06/05 → 30/11/08

Funding

Cancer Research UK

2 Article

Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity
Fernando, I. N., Lax, S., Bowden, S. J., Ahmed, I., Steven, J. H., Churn, M., Brunt, A. M., Agrawal, R. K., Canney, P., Stevens, A. & Rea, D. W., Jun 2023, In: Clinical Oncology. 35, 6, p. 397-407 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Downloads (Pure)
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial
SECRAB Investigators, Jan 2020, In: Radiotherapy and Oncology. 142, p. 52-61
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

157 Downloads (Pure)